The CXC Chemokines IP-10 and Mig Are Necessary for IL-12-Mediated Regression of the Mouse RENCA Tumor
1998 · The Journal of Immunology · 294 citations
https://doi.org/10.4049/jimmunol.161.2.927
C
Charles S. Tannenbaum
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
3.5K
Citations
35
h-index
54
i10-index
Charles S. Tannenbaum is an academic researcher from Cleveland Clinic Lerner College of Medicine. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune cells in cancer & Chemokine receptors and signaling. The author has an h-index of 35, co-authored 77 publications.
Papers by this author
worksCytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12
1996 · The Journal of Immunology · 161 citations
https://doi.org/10.4049/jimmunol.156.2.693
Characterization of lipopolysaccharide-induced macrophage gene expression.
1988 · The Journal of Immunology · 91 citations
https://doi.org/10.4049/jimmunol.140.10.3640
IFN-gamma and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages.
1993 · The Journal of Immunology · 40 citations
https://doi.org/10.4049/jimmunol.151.12.6833
Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain
2015 · Journal of Biological Chemistry · 19 citations
https://doi.org/10.1074/jbc.m115.663898
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat